CD19 and breast cancer: Patients with breast cancer had a lower overall survival rate when certain genes, including CD19, CD79A, CD83, XCL1, BIRC3, BTLA, FCRLA, MS4A1, SPIB, TCL1A, and IGF2R, are expressed at different levels (Fig. 6B).